Cardano Risk Management B.V.
Institutional investor · Portfolio as of Q4 2023
Top Holdings11 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
MICROSOFT CORP | 1.7M | $570.4M | 23.7% | $249.37 | +48.58% | 20 qtrssince 2019-Q1 | Increased 66 |
APPLE INC | 3M | $527.6M | 21.9% | $133.23 | +42.77% | 20 qtrssince 2019-Q1 | Increased 60 |
NVIDIA CORP | 537,725 | $244.3M | 10.1% | $49.49 | 0.00% | 1 qtr | New 74 |
AMAZON.COM INC | 1.8M | $239.9M | 10.0% | $109.43 | +38.84% | 17 qtrssince 2019-Q4 | Increased 56 |
ALPHABET INC-CL A | 1.1M | $149.6M | 6.2% | $103.18 | +34.37% | 20 qtrssince 2019-Q1 | Increased 57 |
ALPHABET INC-CL C | 1.1M | $149.2M | 6.2% | $99.69 | +40.32% | 20 qtrssince 2019-Q1 | Increased 51 |
TESLA INC | 532,352 | $133M | 5.5% | $248.48 | 0.00% | 1 qtr | New 71 |
PROCTER & GAMBLE CO/THE | 729,991 | $106.7M | 4.4% | $136.27 | 0.00% | 1 qtr | New 63 |
UNITEDHEALTH GROUP INC | 192,969 | $98.4M | 4.1% | $505.90 | 0.00% | 1 qtr | New 63 |
ELI LILLY & CO | 176,781 | $96.9M | 4.0% | $572.09 | 0.00% | 1 qtr | New 63 |
JPMORGAN CHASE & CO | 622,006 | $94.1M | 3.9% | $161.96 | 0.00% | 1 qtr | New 63 |
Cardano Risk Management B.V. manages $2.4B across 11 positions as of Q4 2023. Top holdings: MSFT (23.7%), AAPL (21.9%), NVDA (10.1%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 5/5.0.
Active quarter - 6 new positions, 0 exits, 5 increased. Top move: NVDA (NEW, conviction 74). Portfolio: $2.4B across 11 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer